Jagsonpal Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 85.07 | 67.37 | 75.92 |
| Operating Expense | 64.99 | 53.04 | 58.76 |
| Net Profit | 13.19 | 8.76 | 10.95 |
| Net Profit Margin | 15.50% | 13.00% | 14.42% |
| Earning Per Share | 2 | 1.25 | 1.67 |
| EBIDTA | 19.76 | 13.79 | 17.35 |
| Effective Tax Rate | 20.83% | 17.17% | 21.85% |
Particulars
Jun 2026
Revenue85.07
Operating Expense64.99
Net Profit13.19
Net Profit Margin15.50
Earning Per Share2
EBIDTA19.76
Effective Tax Rate20.83
